Location: New York, NY
CIK: 0001609251 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 11, 2023
Total Value: $316M
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BIIB | BIOGEN INC | 176,826 | $50.37M | 16.0% | $267.94 | +11.2% | — | 09062X103 |
| UTHR | UNITED THERAPEUTICS CORP | 202,715 | $44.75M | 14.2% | $127.97 | +73.1% | — | 91307C102 |
| REGN | REGENERON PHARMACEUTICALS | 59,188 | $42.53M | 13.5% | $342.96 | +123.6% | — | 75886F107 |
| EXEL | EXELIXIS INC | 2,133,703 | $40.77M | 12.9% | $18.49 | +4.3% | — | 30161Q104 |
| ALKS | ALKERMES PLC | 1,103,451 | $34.54M | 10.9% | $18.73 | +61.6% | — | G01767105 |
| CAH | CARDINAL HEALTH INC | 353,714 | $33.45M | 10.6% | $56.53 | +42.6% | — | 14149Y108 |
| — | TARO PHARMACEUTICAL INDUS | 643,080 | $24.39M | 7.7% | $70.84 | — | — | M8737E108 |
| EMBC | EMBECTA CORP | 1,070,810 | $23.13M | 7.3% | $25.42 | -3.7% | — | 29082K105 |
| ENTA | ENANTA PHARMACEUTICALS INC | 687,613 | $14.71M | 4.7% | $43.86 | -32.8% | — | 29251M106 |
| VNDA | VANDA PHARMACEUTICALS INC | 362,951 | $2.392M | 0.8% | $10.33 | -37.9% | — | 921659108 |
| KOD | KODIAK SCIENCES INC | 344,634 | $2.378M | 0.8% | $33.04 | -81.5% | — | 50015M109 |
| EGRX | EAGLE PHARMACEUTICALS INC | 113,437 | $2.205M | 0.7% | $44.36 | -46.5% | — | 269796108 |